You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Pharma & Healthcare

Global InVitro Fertilization (IVF) Market Professional Research Report 2021-2027

Market Analysis and Insights: Global InVitro Fertilization (IVF) Market
The research report studies the InVitro Fertilization (IVF) market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global InVitro Fertilization (IVF) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global InVitro Fertilization (IVF) Scope and Segment
The global InVitro Fertilization (IVF) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global InVitro Fertilization (IVF) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
by Type, the market is primarily split into
Intrauterine Insemination (IUI)
Intra Cytoplasmic Sperm Injection (ICSI)
Drug and Hormone Therapies
by Application, this report covers the following segments
Male Infertility
Female Infertility
Global InVitro Fertilization (IVF) market: regional analysis, the major regions covered in the report are:
North America
United States
Rest of Europe
South Korea
Southeast Asia
Rest of Asia-Pacific
Latin America
Middle East & Africa
Saudi Arabia
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The InVitro Fertilization (IVF) key players in this market include:
Vitrolife AB
Merck Serono
Ferring Pharmaceuticals
Irvine Scientific
Cooper Surgical
Halotech Dna
Auxilium Pharmaceuticals
Andrology Solutions
1 Market Overview of InVitro Fertilization (IVF)
1.1 InVitro Fertilization (IVF) Market Overview
1.1.1 InVitro Fertilization (IVF) Product Scope
1.1.2 InVitro Fertilization (IVF) Market Status and Outlook
1.2 Global InVitro Fertilization (IVF) Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global InVitro Fertilization (IVF) Market Size by Region (2016-2027)
1.4 Global InVitro Fertilization (IVF) Historic Market Size by Region (2016-2021)
1.5 Global InVitro Fertilization (IVF) Market Size Forecast by Region (2022-2027)
1.6 Key Regions, InVitro Fertilization (IVF) Market Size (2016-2027)
1.6.1 North America InVitro Fertilization (IVF) Market Size (2016-2027)
1.6.2 Europe InVitro Fertilization (IVF) Market Size (2016-2027)
1.6.3 Asia-Pacific InVitro Fertilization (IVF) Market Size (2016-2027)
1.6.4 Latin America InVitro Fertilization (IVF) Market Size (2016-2027)
1.6.5 Middle East & Africa InVitro Fertilization (IVF) Market Size (2016-2027)

2 InVitro Fertilization (IVF) Market Overview by Type
2.1 Global InVitro Fertilization (IVF) Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global InVitro Fertilization (IVF) Historic Market Size by Type (2016-2021)
2.3 Global InVitro Fertilization (IVF) Forecasted Market Size by Type (2022-2027)
2.4 Intrauterine Insemination (IUI)
2.5 Intra Cytoplasmic Sperm Injection (ICSI)
2.6 Drug and Hormone Therapies
2.7 Others

3 InVitro Fertilization (IVF) Market Overview by Application
3.1 Global InVitro Fertilization (IVF) Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global InVitro Fertilization (IVF) Historic Market Size by Application (2016-2021)
3.3 Global InVitro Fertilization (IVF) Forecasted Market Size by Application (2022-2027)
3.4 Male Infertility
3.5 Female Infertility

4 InVitro Fertilization (IVF) Competition Analysis by Players
4.1 Global InVitro Fertilization (IVF) Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in InVitro Fertilization (IVF) as of 2020)
4.3 Date of Key Players Enter into InVitro Fertilization (IVF) Market
4.4 Global Top Players InVitro Fertilization (IVF) Headquarters and Area Served
4.5 Key Players InVitro Fertilization (IVF) Product Solution and Service
4.6 Competitive Status
4.6.1 InVitro Fertilization (IVF) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles and Key Data
5.1 Vitrolife AB
5.1.1 Vitrolife AB Profile
5.1.2 Vitrolife AB Main Business
5.1.3 Vitrolife AB InVitro Fertilization (IVF) Products, Services and Solutions
5.1.4 Vitrolife AB InVitro Fertilization (IVF) Revenue (US$ Million) & (2016-2021)
5.1.5 Vitrolife AB Recent Developments
5.2 Merck Serono
5.2.1 Merck Serono Profile
5.2.2 Merck Serono Main Business
5.2.3 Merck Serono InVitro Fertilization (IVF) Products, Services and Solutions
5.2.4 Merck Serono InVitro Fertilization (IVF) Revenue (US$ Million) & (2016-2021)
5.2.5 Merck Serono Recent Developments
5.3 Ferring Pharmaceuticals
5.3.1 Ferring Pharmaceuticals Profile
5.3.2 Ferring Pharmaceuticals Main Business
5.3.3 Ferring Pharmaceuticals InVitro Fertilization (IVF) Products, Services and Solutions
5.3.4 Ferring Pharmaceuticals InVitro Fertilization (IVF) Revenue (US$ Million) & (2016-2021)
5.3.5 Irvine Scientific Recent Developments
5.4 Irvine Scientific
5.4.1 Irvine Scientific Profile
5.4.2 Irvine Scientific Main Business
5.4.3 Irvine Scientific InVitro Fertilization (IVF) Products, Services and Solutions
5.4.4 Irvine Scientific InVitro Fertilization (IVF) Revenue (US$ Million) & (2016-2021)
5.4.5 Irvine Scientific Recent Developments
5.5 GeneaBiomedx
5.5.1 GeneaBiomedx Profile
5.5.2 GeneaBiomedx Main Business
5.5.3 GeneaBiomedx InVitro Fertilization (IVF) Products, Services and Solutions
5.5.4 GeneaBiomedx InVitro Fertilization (IVF) Revenue (US$ Million) & (2016-2021)
5.5.5 GeneaBiomedx Recent Developments
5.6 Cooper Surgical
5.6.1 Cooper Surgical Profile
5.6.2 Cooper Surgical Main Business
5.6.3 Cooper Surgical InVitro Fertilization (IVF) Products, Services and Solutions
5.6.4 Cooper Surgical InVitro Fertilization (IVF) Revenue (US$ Million) & (2016-2021)
5.6.5 Cooper Surgical Recent Developments
5.7 Origio
5.7.1 Origio Profile
5.7.2 Origio Main Business
5.7.3 Origio InVitro Fertilization (IVF) Products, Services and Solutions
5.7.4 Origio InVitro Fertilization (IVF) Revenue (US$ Million) & (2016-2021)
5.7.5 Origio Recent Developments
5.8 Genea
5.8.1 Genea Profile
5.8.2 Genea Main Business
5.8.3 Genea InVitro Fertilization (IVF) Products, Services and Solutions
5.8.4 Genea InVitro Fertilization (IVF) Revenue (US$ Million) & (2016-2021)
5.8.5 Genea Recent Developments
5.9 Halotech Dna
5.9.1 Halotech Dna Profile
5.9.2 Halotech Dna Main Business
5.9.3 Halotech Dna InVitro Fertilization (IVF) Products, Services and Solutions
5.9.4 Halotech Dna InVitro Fertilization (IVF) Revenue (US$ Million) & (2016-2021)
5.9.5 Halotech Dna Recent Developments
5.10 Auxilium Pharmaceuticals
5.10.1 Auxilium Pharmaceuticals Profile
5.10.2 Auxilium Pharmaceuticals Main Business
5.10.3 Auxilium Pharmaceuticals InVitro Fertilization (IVF) Products, Services and Solutions
5.10.4 Auxilium Pharmaceuticals InVitro Fertilization (IVF) Revenue (US$ Million) & (2016-2021)
5.10.5 Auxilium Pharmaceuticals Recent Developments
5.11 Auxogyn
5.11.1 Auxogyn Profile
5.11.2 Auxogyn Main Business
5.11.3 Auxogyn InVitro Fertilization (IVF) Products, Services and Solutions
5.11.4 Auxogyn InVitro Fertilization (IVF) Revenue (US$ Million) & (2016-2021)
5.11.5 Auxogyn Recent Developments
5.12 Ovascience
5.12.1 Ovascience Profile
5.12.2 Ovascience Main Business
5.12.3 Ovascience InVitro Fertilization (IVF) Products, Services and Solutions
5.12.4 Ovascience InVitro Fertilization (IVF) Revenue (US$ Million) & (2016-2021)
5.12.5 Ovascience Recent Developments
5.13 Andrology Solutions
5.13.1 Andrology Solutions Profile
5.13.2 Andrology Solutions Main Business
5.13.3 Andrology Solutions InVitro Fertilization (IVF) Products, Services and Solutions
5.13.4 Andrology Solutions InVitro Fertilization (IVF) Revenue (US$ Million) & (2016-2021)
5.13.5 Andrology Solutions Recent Developments

6 North America
6.1 North America InVitro Fertilization (IVF) Market Size by Country (2016-2027)
6.2 United States
6.3 Canada

7 Europe
7.1 Europe InVitro Fertilization (IVF) Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe

8 Asia-Pacific
8.1 Asia-Pacific InVitro Fertilization (IVF) Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific

9 Latin America
9.1 Latin America InVitro Fertilization (IVF) Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America

10 Middle East & Africa
10.1 Middle East & Africa InVitro Fertilization (IVF) Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa

11 InVitro Fertilization (IVF) Market Dynamics
11.1 InVitro Fertilization (IVF) Industry Trends
11.2 InVitro Fertilization (IVF) Market Drivers
11.3 InVitro Fertilization (IVF) Market Challenges
11.4 InVitro Fertilization (IVF) Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
  • PUBLISHED DATE: May, 2021
  • NO OF PAGES: 125